From clinicians and researchers

Do you agree?

Three statements about what critically ill patients need — and what does not currently exist. Read each one, mark whether you agree, and add your voice directly on this page. It takes under two minutes.

Three statements

Tell us where you stand

Statements 1 and 2 describe clinical realities independent of Hemocorr — any practising intensivist can respond based on their own experience. Statement 3 is about the combined concept; you may wish to read the clinical brief first.

Statement 01 — Real-time monitoring

A device that can continuously monitor the blood levels of multiple analytes simultaneously in real time would be highly beneficial to critically ill patients.

Continuous, multi-analyte blood chemistry — without repeated draws or laboratory delays — would change what is possible in the ICU.

✓ Noted — you agree with Statement 1

Noted — you don't agree with Statement 1

Statement 02 — Drug-free correction

A device that can correct the levels of multiple blood analytes without drugs — more selectively than existing devices such as dialysis — would be of significant clinical value.

Targeted, drug-free correction of specific blood chemistry imbalances, without the non-selectivity of dialysis or the side effects of pharmacological intervention.

✓ Noted — you agree with Statement 2

Noted — you don't agree with Statement 2

Statement 03 — The combined platform

A single device combining real-time multi-analyte monitoring with targeted, drug-free correction in one closed loop would be of major benefit to critically ill patients — and is worth building.

This is the Hemocorr concept. You may wish to read the clinical brief or technical brief before responding.

✓ Noted — you agree with Statement 3

Noted — you don't agree with Statement 3

Your real name and institution add significant weight to your response and help others who visit this page understand that practising clinicians have engaged with this concept.

Your name (optional)

Title & institution (optional)

Anything else you'd like to add (optional)

I am happy for my name, title, and response to be displayed publicly on this page.

Prefer to keep your communication private? Email Dr. Chander directly at bal@hemocorr.com — emails are read personally and never shared or published without your explicit permission.

Responses received

What clinicians are saying

Named responses appear here once reviewed. Anonymous responses are counted but not displayed individually. This page updates as new responses come in.

—Total responses

—Named responses

—Agree Hemocorr worth building

Statement 01 — Real-time monitoring

No responses yet — be the first to add your voice.

Statement 02 — Drug-free correction

No responses yet — be the first to add your voice.

Statement 03 — The combined platform

No responses yet — be the first to add your voice.

From the inventor

A personal note

I am a pathologist, not a clinician. I have never run an ICU. The clinical problem that Hemocorr is designed to solve is one I understand from the postmortem room — from seeing, after the fact, what was happening in patients' organs at the time of death and realising that we had almost no real-time data about it while they were alive.

If you work in intensive care and find yourself nodding or shaking your head at these statements, I would genuinely value hearing from you. Agreement matters. Disagreement matters equally — it tells me where the concept needs to be reconsidered. Either way, a response from someone who lives with this problem every day is worth more to me than any market research report.

Dr. Bal Chander · bal@hemocorr.com · +91 70180 64940